about
Identification of a human gamma-glutamyl cleaving enzyme related to, but distinct from, gamma-glutamyl transpeptidaseIsolation and sequence analysis of a novel human tyrosine kinase geneAspartylglycosaminuria in the Finnish population: identification of two point mutations in the heavy chain of glycoasparaginaseThe chronic myelocytic cell line K562 contains a breakpoint in bcr and produces a chimeric bcr/c-abl transcriptThe FER gene is evolutionarily conserved and encodes a widely expressed member of the FPS/FES protein-tyrosine kinase familyA t(4;22) in a meningioma points to the localization of a putative tumor-suppressor gene.Alternative processing and developmental control of the transcripts of the Drosophila abl oncogene homologue.Recombinant tumor necrosis factor alpha and interleukin 1 alpha increase expression of c-abl protooncogene mRNA in cultured human marrow stromal cells.Breakpoints on chromosomes 9 and 22 in Philadelphia chromosome-positive chronic myelogenous leukemia (CML). Amplification of rearranged c-abl oncogenes in CML blast crisis.Localization of gelsolin proximal to ABL on chromosome 9ABR, an active BCR-related geneDuplication of the bcr and gamma-glutamyl transpeptidase genesNormal cellular and transformation-associated abl proteins share common sites for protein kinase C phosphorylation.Detection of c-abl tyrosine kinase activity in vitro permits direct comparison of normal and altered abl gene productsCell lines and clinical isolates derived from Ph1-positive chronic myelogenous leukemia patients express c-abl proteins with a common structural alteration.The first BCR gene intron contains breakpoints in Philadelphia chromosome positive leukemia.
P2860
Q24293328-C562BC98-BF3F-47E2-9A6B-FA1233ED0630Q24339490-7BFEE8F7-189C-464C-AE9B-4029C7C74A29Q24563703-ACF1DD75-E773-4D26-89DA-39E6CE233489Q24615435-03076100-0294-4775-863C-B249258C4745Q24631064-B6CB959A-BCC3-4FC2-8B4C-5F06C47ECF60Q30501644-0370817E-4A6D-4373-A696-471BD14F0D7BQ33931795-3D13B16F-B556-46E6-AD9C-F9A5F5FD3212Q34302049-AB943449-6D90-4D83-9919-DFE3EE4C78DDQ34547475-8E5CC3C0-9868-4335-B3C0-8981F85ED2C6Q35245858-05E6A634-F31D-45CF-9E59-9AD16338C844Q35953624-38DB66A1-4BD7-4959-8DB4-82FD11D96BBFQ36063891-5C175F4F-86E7-4691-9594-395E4890F396Q36924977-265C1F2E-61E1-4F26-B45C-261DCA79F93EQ36951425-A0E61CEA-AE0C-4A8E-B266-1522007E730CQ37680879-035140CE-5F3B-4AF7-85E0-5EFBFB78ACB4Q40556706-83EB1291-E2B6-4F19-8F70-3156F619BC7F
P2860
description
1983 nî lūn-bûn
@nan
1983 թուականին հրատարակուած գիտական յօդուած
@hyw
1983 թվականին հրատարակված գիտական հոդված
@hy
1983年の論文
@ja
1983年論文
@yue
1983年論文
@zh-hant
1983年論文
@zh-hk
1983年論文
@zh-mo
1983年論文
@zh-tw
1983年论文
@wuu
name
The human v-abl cellular homologue
@ast
The human v-abl cellular homologue
@en
The human v-abl cellular homologue
@nl
type
label
The human v-abl cellular homologue
@ast
The human v-abl cellular homologue
@en
The human v-abl cellular homologue
@nl
prefLabel
The human v-abl cellular homologue
@ast
The human v-abl cellular homologue
@en
The human v-abl cellular homologue
@nl
P2093
P1476
The human v-abl cellular homologue
@en
P2093
Heisterkamp N
Stephenson JR
P407
P577
1983-01-01T00:00:00Z